Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
O BCG é uma vacina preparada com germes vivos e atenuados, utilizada para a imunização contra a tuberculose. Ainda que não confira completa imunidade às pessoas vacinadas, promove aumento de resistência contra a referida doença. O Grupo Técnico de Estudos, em suas várias reuniões, tomou conheciment...
| Published in: | Revista Brasileira de Cancerologia |
|---|---|
| Main Authors: | Humberto Torloni, Adayr Eiras de Araújo, Hiram Silveira Lucas, Aldemar Neves Filho, Alfredo Norberto Bica, Álvaro Alberto S. Pontes, Antonio Oliveira Lima, J. Fonseca da Cunha, José Ramos Júnior, Milton Fontes Magarão |
| Format: | Article |
| Language: | English |
| Published: |
Instituto Nacional de Câncer (INCA)
2023-08-01
|
| Subjects: | |
| Online Access: | https://rbc.inca.gov.br/index.php/revista/article/view/3822 |
Similar Items
Normas e Recomendações para o Emprego do BCG em Câncer
by: Humberto Torloni, et al.
Published: (2023-08-01)
by: Humberto Torloni, et al.
Published: (2023-08-01)
Grupo Técnico de Estudos do BCG em Câncer: julho de 1976: Rio de Janeiro - Brasil
by: Humberto Torloni
Published: (2023-08-01)
by: Humberto Torloni
Published: (2023-08-01)
Recomendação Especial
by: Humberto Torloni, et al.
Published: (2023-08-01)
by: Humberto Torloni, et al.
Published: (2023-08-01)
Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)
by: Roberta Monardo, et al.
Published: (2025-01-01)
A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)
by: V.L. Petricevich, et al.
Published: (2001-01-01)
Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
by: Susan M Pereira, et al.
Published: (2007-09-01)
by: Susan M Pereira, et al.
Published: (2007-09-01)
Um caso de adenite por BCG
by: Marta Sousa Tavares, et al.
Published: (2014-09-01)
by: Marta Sousa Tavares, et al.
Published: (2014-09-01)
Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review
by: Marta Marques, et al.
Published: (2020-11-01)
by: Marta Marques, et al.
Published: (2020-11-01)
Acute tenosynovitis following an accidental injection of Bacille Calmette-Guérin (BCG) in a health care worker: A case report
by: Mieko Tokano, et al.
Published: (2024-03-01)
by: Mieko Tokano, et al.
Published: (2024-03-01)
Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
by: Magdalena Jurczak, et al.
Published: (2025-02-01)
by: Magdalena Jurczak, et al.
Published: (2025-02-01)
Sobre o BCG na Imunização Ativa Inespecífica em Cancerologia
by: José Rosemberg
Published: (2023-08-01)
by: José Rosemberg
Published: (2023-08-01)
HUBUNGAN RIWAYAT STATUS IMUNISASI BACILLE CALMETTE-GUÉRIN (BCG) DENGAN KEJADIAN TUBERKULOSIS (TB) PADA ANAK DI BADAN LAYANAN UMUM DAERAH RUMAH SAKIT UMUM CUT MEUTIA ACEH UTARA TAHUN 2015
by: Hedya Nadhrati Surura, et al.
Published: (2018-02-01)
by: Hedya Nadhrati Surura, et al.
Published: (2018-02-01)
The safety of BCG revaccination in the context of COVID-19
by: Adriana Sánchez-García, et al.
Published: (2023-12-01)
by: Adriana Sánchez-García, et al.
Published: (2023-12-01)
Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)
by: Azad H.A. Razack
Published: (2007-10-01)
Evolution of the Bacillus Calmette-Guérin scar Russia and Moreau strains in newborns: A brazilian cohort
by: Ramon Andrade de Souza, et al.
Published: (2023-08-01)
by: Ramon Andrade de Souza, et al.
Published: (2023-08-01)
TUBERCULOSE DE ARCO COSTAL EM LACTENTE: UM RELATO DE CASO
by: Alexia Lavínia Holanda Gama, et al.
Published: (2023-10-01)
by: Alexia Lavínia Holanda Gama, et al.
Published: (2023-10-01)
Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
by: Akihito Kawai, et al.
Published: (2022-11-01)
by: Akihito Kawai, et al.
Published: (2022-11-01)
One hundred years of BCG: the journey of tuberculosis vaccination in Brazil
by: Eloise Trostdorf Monteiro Filardi, et al.
Published: (2025-09-01)
by: Eloise Trostdorf Monteiro Filardi, et al.
Published: (2025-09-01)
Perianal Plasmoacanthoma After BCG-Immunotherapy: Case Report and Review of Literature
by: Masoumeh Roohaninasab, et al.
Published: (2022-07-01)
by: Masoumeh Roohaninasab, et al.
Published: (2022-07-01)
Observational study to estimate the changes in the effectiveness of bacillus Calmette–Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
by: Punam Mangtani, et al.
Published: (2017-07-01)
by: Punam Mangtani, et al.
Published: (2017-07-01)
A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)
by: Masashi Nishimura, et al.
Published: (2023-01-01)
Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01)
by: Samuel T. Pasco, et al.
Published: (2020-09-01)
[Fever of Unknown Origin in a Patient Administered With Bacillus Calmette-Guérin (BCG) to Treat Urothelial Vesical Carcinoma in Situ]
by: Paolo Ghiringhelli, et al.
Published: (2023-07-01)
by: Paolo Ghiringhelli, et al.
Published: (2023-07-01)
Establishment of an in vitro model of monocyte-like THP-1 cells for trained immunity induced by bacillus Calmette-Guérin
by: Jin-Chuan Xu, et al.
Published: (2024-04-01)
by: Jin-Chuan Xu, et al.
Published: (2024-04-01)
Pyoderma gangrenosum arising at the site of BCG immunization in a nine-month-old girl
by: Yuka Okura, et al.
Published: (2025-07-01)
by: Yuka Okura, et al.
Published: (2025-07-01)
Osteomielitis de tibia secundaria a la vacuna BCG en un paciente pediátrico inmunocompetente. Reporte de un caso
by: Javier Eugenio Dal Lago, et al.
Published: (2020-05-01)
by: Javier Eugenio Dal Lago, et al.
Published: (2020-05-01)
Future of TB Prevention: An Alternative To BCG
by: Sneka P, et al.
Published: (2022-10-01)
by: Sneka P, et al.
Published: (2022-10-01)
Machine learning-assisted genomic profiling to identify differences between Bacillus Calmette-Guérin (BCG) vaccine strains and non-BCG wild-type Mycobacterium bovis
by: Yunyun Shi, et al.
Published: (2025-09-01)
by: Yunyun Shi, et al.
Published: (2025-09-01)
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
by: Nicole L Messina, et al.
Published: (2025-01-01)
by: Nicole L Messina, et al.
Published: (2025-01-01)
Effect of salidroside on the immune function of BCG-infected macrophages
by: NI Shuyi, et al.
Published: (2025-04-01)
by: NI Shuyi, et al.
Published: (2025-04-01)
Decoding the BCG and COVID-19 connection: an empirical analysis
by: Nand Lal Mishra, et al.
Published: (2024-05-01)
by: Nand Lal Mishra, et al.
Published: (2024-05-01)
Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01)
by: Lwandile Bukula, et al.
Published: (2025-03-01)
Harnessing <i>Mycobacterium bovis</i> BCG Trained Immunity to Control Human and Bovine Babesiosis
by: Reginaldo G. Bastos, et al.
Published: (2022-01-01)
by: Reginaldo G. Bastos, et al.
Published: (2022-01-01)
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland
by: Saba Savul, et al.
Published: (2023-12-01)
by: Saba Savul, et al.
Published: (2023-12-01)
Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
by: Ryan K. Meyer, M.D., et al.
Published: (2020-05-01)
by: Ryan K. Meyer, M.D., et al.
Published: (2020-05-01)
Rifampin-Resistant Mycobacterium bovis BCG–Induced Disease in HIV-Infected Infant, Vietnam
by: Duc Nguyen Hong, et al.
Published: (2013-07-01)
by: Duc Nguyen Hong, et al.
Published: (2013-07-01)
Infantile Disseminated Bacille Calmette–Guérin Disease with Hemophagocytosis and Mimicking Juvenile Myelomonocytic Leukemia: A Case Report with Concise Literature Review
by: Vishwapriya Mahadev Godkhindi, et al.
Published: (2024-06-01)
by: Vishwapriya Mahadev Godkhindi, et al.
Published: (2024-06-01)
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence
by: Douglas S. Kernodle, et al.
Published: (2013-01-01)
by: Douglas S. Kernodle, et al.
Published: (2013-01-01)
Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01)
by: C. Kanipe, et al.
Published: (2022-11-01)
Similar Items
-
Normas e Recomendações para o Emprego do BCG em Câncer
by: Humberto Torloni, et al.
Published: (2023-08-01) -
Grupo Técnico de Estudos do BCG em Câncer: julho de 1976: Rio de Janeiro - Brasil
by: Humberto Torloni
Published: (2023-08-01) -
Recomendação Especial
by: Humberto Torloni, et al.
Published: (2023-08-01) -
Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01) -
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)
